Brian Lenz, VP, CFO at ADMA BIOLOGICS, INC. (ADMA), bought 5,000 shares at $4.78 ($24K) on 2018-06-08, disclosed to the SEC on 2018-06-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| ADMA | BUY | 2021-10-26 | $30K | — | Filing → |
| ADMA | BUY | 2020-08-12 | $12K | — | Filing → |
| ADMA | BUY | 2020-02-11 | $25K | — | Filing → |